April 25, 2023 Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts Evaluating the clinical benefit of interventions aimed at treating conditions with heterogeneous symptom....
April 24, 2023 Leveraging Biolink as a “Rosetta Stone” Between C-Path and EJP-RD Semantic Models Provides Emergent Interoperability
April 20, 2023 CRDSA Secondary Use Data Sharing Webinar Please join the Clinical Research Data Sharing Alliance on Thursday, April 20, for “Secondary Use Data: What do R
April 18, 2023-April 20, 2023 April 18 – 20 | 2023 CDRC Annual Meeting C-Path’s Cure Drug Repurposing Collaboratory will host an in-person, three-day annual Conference and Regulatory Workshop
April 14, 2023 Rare Disease COA Consortium Announces Publication of Open Access Article C-Path’s Rare Disease COA Consortium is pleased to announce that “Approaches to the Assessment of Clinical Benefit of Treatmen
April 9, 2023-April 10, 2023 14th Annual Patient-Reported Outcome Consortium Workshop April 19 – 20, 2023 DoubleTree by Hilton Silver Spring DC North 8777 Georgia Avenue Silver Spring, MD 20910 On April 19–20, 20
March 29, 2023 C-Path Appoints Key Scientific Leaders to Executive Roles Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the..
March 17, 2023 The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Appropriate endpoint selection for rare disease trials is challenging. The Rare Disease Clinical Outcome Assessment (COA)....
March 16, 2023 Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature According to the latest guidelines by the Infectious Disease Society of America (IDSA), there is no defined standard of care for..